BRIEF-AstraZeneca says FDA approves drug for rare body fat disorder

Tue Feb 25, 2014 1:33pm EST

Related Topics

Feb 25 (Reuters) - AstraZeneca PLC : * FDA approves orphan drug Myalept * Myalept, a recombinant analogue of human leptin, is the first and only treatment approved by the FDA for these patients * To make Myalept available to patients as soon as possible in the US. * Is working to complete transfer of the Biologics License Application (BLA) for Myalept from Bristol-Myers Squibb company to Astrazeneca * Source text for Eikon: * For more news, please click here